The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
CS1001-304: A phase III study of fluorouracil and cisplatin (FP) with CS1001, an anti-PD-L1 antibody, or placebo in unresectable locally advanced, recurrent or metastatic esophageal squamous cell carcinoma (ESCC).
 
Jin Li
No Relationships to Disclose
 
Yuxian Bai
No Relationships to Disclose
 
Qingshan Li
No Relationships to Disclose
 
YouEn Lin
No Relationships to Disclose
 
Hao Jiang
No Relationships to Disclose
 
Zhendong Chen
No Relationships to Disclose
 
Rong Huang
No Relationships to Disclose
 
Na Li
No Relationships to Disclose
 
Yanxia JI
No Relationships to Disclose
 
Shujun Yang
No Relationships to Disclose
 
Wensheng Qiu
No Relationships to Disclose
 
Bo Liu
No Relationships to Disclose
 
Jufeng Wang
No Relationships to Disclose
 
Kangsheng Gu
No Relationships to Disclose
 
Jie Fu
Employment - CStone Pharmaceuticals
 
Bo Wang
Employment - CStone Pharmaceuticals
 
Jin Hu
Employment - CStone Pharmaceuticals
 
Yan Xu
Employment - CStone Pharmaceuticals
 
Qingmei Shi
Employment - CStone Pharmaceuticals
Stock and Other Ownership Interests - CStone Pharmaceuticals
 
Jianxin Yang
Employment - CStone Pharmaceuticals
Leadership - CStone Pharmaceuticals
Stock and Other Ownership Interests - CStone Pharmaceuticals